Variola Major (Smallpox) Completed Phase 2 Trials for Tecovirimat (DB12020)

Also known as: Small Pox / Smallpox / Smallpox (disorder) / Variola major (disorder) / Smallpox, unspecified

IndicationStatusPhase
DBCOND0038255 (Variola Major (Smallpox))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04957485Study to Assess the Safety and Pharmacokinetics of TPOXX® When Administered Orally for 28 DaysTreatment